An integrated in silico immuno-genetic analytical platform provides insights into COVID-19 serological and vaccine targets

During COVID-19, diagnostic serological tools and vaccines have been developed. To inform control activities in a post-vaccine surveillance setting, we have developed an online “immuno-analytics” resource that combines epitope, sequence, protein and SARS-CoV-2 mutation analysis. SARS-CoV-2 spike and nucleocapsid proteins are both vaccine and serological diagnostic targets. Using the tool, the nucleocapsid protein appears to be a sub-optimal target for use in serological platforms. Spike D614G (and nsp12 L314P) mutations were most frequent (> 86%), whilst spike A222V/L18F have recently increased. Also, Orf3a proteins may be a suitable target for serology. The tool can accessed from: http://genomics.lshtm.ac.uk/immuno (online); https://github.com/dan-ward-bio/COVID-immunoanalytics (source code).

[1]  J. Bloom,et al.  Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020 , 2020, medRxiv.

[2]  M. Shrotri,et al.  Keeping track of the SARS-CoV-2 vaccine pipeline , 2020, Nature Reviews Immunology.

[3]  D. Cummings,et al.  A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity , 2020, Nature Communications.

[4]  D. A. Jackson,et al.  Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.

[5]  M. Koopmans,et al.  An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment , 2020, Nature Communications.

[6]  William P. Hanage,et al.  Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear , 2020, Cell.

[7]  S. Rowland-Jones,et al.  Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.

[8]  Yusuke Nakamura,et al.  Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2 , 2020, Journal of Human Genetics.

[9]  Elisabeth Mahase.  Covid-19: Confidentiality agreements allow antibody test manufacturers to withhold evaluation results , 2020, BMJ.

[10]  D. Montefiori,et al.  Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2 , 2020, bioRxiv.

[11]  T. Clark,et al.  Controlling the SARS-CoV-2 outbreak, insights from large scale whole genome sequences generated across the world , 2020, bioRxiv.

[12]  X. Tang,et al.  Antibody responses to SARS-CoV-2 in patients with COVID-19 , 2020, Nature Medicine.

[13]  K. Krogfelt,et al.  Evaluation of nine commercial SARS-CoV-2 immunoassays , 2020, medRxiv.

[14]  Zacharias E. Andreadakis,et al.  The COVID-19 vaccine development landscape , 2020, Nature Reviews Drug Discovery.

[15]  C. Whittaker,et al.  Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.

[16]  Y. Wen,et al.  Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications , 2020, medRxiv.

[17]  Xiaobo Yu,et al.  SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution , 2020, bioRxiv.

[18]  Y. Yazdanpanah,et al.  SARS-CoV-2 specific antibody responses in COVID-19 patients , 2020, medRxiv.

[19]  R. Scheuermann,et al.  A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2 , 2020, Cell Host & Microbe.

[20]  E. Dong,et al.  An interactive web-based dashboard to track COVID-19 in real time , 2020, The Lancet Infectious Diseases.

[21]  Russ B. Altman,et al.  Predicting HLA class II antigen presentation through integrated deep learning , 2019, Nature Biotechnology.

[22]  K. Yuen,et al.  Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3‐dependent ubiquitination of ASC , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  Alessandro Sette,et al.  The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..

[24]  M. Nielsen,et al.  NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.

[25]  Gene I. Sher,et al.  DRREP: deep ridge regressed epitope predictor , 2017, BMC Genomics.

[26]  Bjoern Peters,et al.  BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes , 2017, Nucleic Acids Res..

[27]  Jianjun Luo,et al.  BioCircos.js: an interactive Circos JavaScript library for biological data visualization on web applications , 2016, Bioinform..

[28]  R. Liddington,et al.  Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness , 2014, Journal of Virology.

[29]  Fu-Tong Liu,et al.  Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins , 2014, Biochemical and Biophysical Research Communications.

[30]  Jincun Zhao,et al.  Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection , 2014, Journal of Virology.

[31]  Harinder Singh,et al.  Improved Method for Linear B-Cell Epitope Prediction Using Antigen’s Primary Sequence , 2013, PloS one.

[32]  K. Katoh,et al.  MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.

[33]  A. Bertoletti,et al.  Engineering T Cells Specific for a Dominant Severe Acute Respiratory Syndrome Coronavirus CD8 T Cell Epitope , 2011, Journal of Virology.

[34]  Aaron R. Quinlan,et al.  Bioinformatics Applications Note Genome Analysis Bedtools: a Flexible Suite of Utilities for Comparing Genomic Features , 2022 .

[35]  Faizan Ahmad,et al.  The SARS Coronavirus 3a Protein Causes Endoplasmic Reticulum Stress and Induces Ligand-Independent Downregulation of the Type 1 Interferon Receptor , 2009, PloS one.

[36]  Ya. I. Davydov,et al.  Prediction of linear B-cell epitopes , 2009, Molecular Biology.

[37]  Hanzhong Wang,et al.  Humoral and Cellular Immune Responses Induced by 3a DNA Vaccines against Severe Acute Respiratory Syndrome (SARS) or SARS-Like Coronavirus in Mice , 2008, Clinical and Vaccine Immunology.

[38]  A. McMichael,et al.  T Cell Responses to Whole SARS Coronavirus in Humans1 , 2008, The Journal of Immunology.

[39]  Sudipto Saha,et al.  Prediction of continuous B‐cell epitopes in an antigen using recurrent neural network , 2006, Proteins.

[40]  Zu-feng Guo,et al.  Amino terminus of the SARS coronavirus protein 3a elicits strong, potentially protective humoral responses in infected patients. , 2006, The Journal of general virology.

[41]  Ruifu Yang,et al.  Response of Memory CD8+ T Cells to Severe Acute Respiratory Syndrome (SARS) Coronavirus in Recovered SARS Patients and Healthy Individuals1 , 2005, The Journal of Immunology.

[42]  Hao Shen,et al.  Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein , 2005, Virology.

[43]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[44]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[45]  Eriko,et al.  Analytical sensitivity and efficiency comparisons of SARS-COV-2 qRT-PCR assays , 2020 .

[46]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..